| 3D* Labels (Dandenong Division of General Practice) |
Graeme Sweet |
(3CPA) |
| Allergic Rhinitis Self-management Program in Community Pharmacy |
Dr Lorraine Smith |
(4CPA) |
| Asthma self-management in the community: pharmacists facilitating empowerment of patient asthma self-management practices through collaboration |
Dr Sinthia Bosnic- Anticevich |
(3CPA) |
| Building Organisation Flexibility to Promote the Implementation of Primary Care Service in Community Pharmacy |
Professor Charlie Benrimoj |
(4CPA) |
| Case conferences and care planning – Collaboration between community pharmacists and general practitioners |
Dr Tim Chen |
(3CPA) |
| Change management and community pharmacy |
Distinguished Professor Dexter Dunphy |
(3CPA) |
| Chronic Illness |
Professor Amanda Wheeler, Griffith University |
(5CPA) |
| Collaboration between CP & mental health care practitioners |
Dr Paula Whitehead |
(3CPA) |
| A Collaborative Screening, Referral and Management Process to Improve Health Outcomes in Chronic Obstructive Pulmonary Disease (COPD) |
Ms Heather Allen |
(4CPA) |
| A community pharmacist delivered therapeutics outcome monitoring service for hyperlipidemia |
Dr Parisa Aslani |
(3CPA) |
| A community pharmacy based anticoagulant management service |
Dr Andrew McLachlan |
(3CPA) |
| Community pharmacists providing clinical services for dispensing doctors and depot pharmacies in rural Queensland – tele-pharmacy |
Dr Lisa Nissen |
(3CPA) |
| Community Pharmacy Medication Incident and Reporting Management System (CPMIRMS) (PROMISe) |
Professor Greg Peterson |
(3CPA) |
| Community Pharmacy Promoting Appropriate Sedative Use in Aged Care Facilities: the ReDUSe project |
Professor Greg Peterson |
(4CPA) |
| Community Pharmacy Research Support Centre |
Professor Carol Armour |
(3CPA) |
| Consumer Access to Prescription Medicines |
Wayne Kinrade |
(3CPA) |
| Consumer Experiences, Needs and Expectations of Community Pharmacy |
Dr Kathy Mott |
(3CPA) |
| Consumer Needs |
John Cannings, PricewaterhouseCoopers |
(5CPA) |
| Consumer perceptions of supply of and access to consumer medicines |
Mr Paul Zadow |
(4CPA) |
| Cost benefit analysis of pharmacist only and pharmacy medicines and a risk based evaluation of the standards |
Professor Charlie Benrimoj |
(3CPA) |
| Customised education programs for patients with Diabetes Mellitus – Use of Structured Questionnaires and Education Modules |
Jeffery Hughes |
(3CPA) |
| To Develop and Pilot a Best Practice Community Pharmacy Chlamydia Screening Model |
Dr Rhonda Clifford |
(4CPA) |
| Developing a sustainable Pharmacy Support Network to address geographical issues associated with quality use of medicines |
Fiona Kelly |
(3CPA) |
| Development and evaluation of a computerised system for the provision and documentation of community pharmacists’ cognitive services |
Professor Greg Peterson |
(3CPA) |
| Development, Implementation and Evaluation of Funding Model Options for the Dispensing of Pharmacotherapies for Opioid Dependence in Community Pharmacy (Addiction Care 1) |
Wayne Kinrade |
(3CPA) |
| Dispensing and Monitoring of Schedule 8 and Schedule 4 (with dependency properties) Drugs (Addiction Care 2) |
Chris Lynton-Moll |
(3CPA) |
| Documenting Clinical Interventions in Community Pharmacy: PROMISe III |
Professor Gregory Peterson |
(4CPA) |
| The economics of pharmaceutical services for methadone services in a public clinic and community pharmacies |
Professor Bruce Sunderland |
(3CPA) |
| Educating community pharmacists to provide quality advice and information to consumers via the internet |
Professor Chris Silagy |
(3CPA) |
| Effectiveness and cost effectiveness of Dose Administration Aids |
Professor Michael Roberts |
(3CPA) |
| Effectiveness and cost effectiveness of Dose Administration Aids – phase 3 (DAA phase 3) |
Professor Michael Roberts |
(3CPA) |
| Enhancing the value of pharmacists through augmented competency standards and targeted professional practice standards |
Bill Kelly |
(3CPA) |
| Ensuring the appropriateness of topical over-the-counter antifungal agents for clients with self-diagnosed vaginal thrush |
Peter Tenni |
(3CPA) |
| Evaluation of Clinical Interventions within Community Pharmacy (PROMISe II) |
Professor Greg Peterson |
(3CPA) |
| Evaluation of HMR Program |
John Schwartzkoff |
(3CPA) |
| Evaluation of the Medicine Information for consumers (MIC) program |
Murray Bento |
(3CPA) |
| Evaluation of the Quality Care Pharmacy Program |
John Chapman |
(3CPA) |
| Evaluation of the R&D Program |
Professor Rosemary Calder |
(3CPA) |
| Facilitating quality use of medicines between hospital and community (Med-E-Support) |
Professor Greg Peterson |
(3CPA) |
| Health Literacy |
Gregory Duncan, Monash University |
(5CPA) |
| HMR: Refining patient eligibility criteria |
Wayne Kinrade, Healthcare Management Advisors |
(5CPA) |
| From hospital to community: a multidisplinary “continuity of care” model for cardiovascular patients involving community pharmacists |
Dr Tim Chen |
(3CPA) |
| Hypertension: Improving patient compliance and clinical outcomes through community pharmacist managed care |
Dr Jeffery Hughes |
(3CPA) |
| Implementing and Evaluating a Parallel Post-discharge Home Medicines Review (HMR) Model |
Dr Manya Angley |
(4CPA) |
| Improving Australian’s access to prescription medicines: Development of pharmacy practice models |
Dr Tracey Bessell |
(3CPA) |
| Improving medication management of palliative care patients: enhancing the role of community pharmacists |
Professor Roger Nation |
(3CPA) |
| Improving the quality, effectiveness and sustainability of smoking cessation services, delivered through community pharmacies |
Professor Andrew Gilbert |
(3CPA) |
| Increasing Community Pharmacy Involvement in the Prevention of Cardiovascular Disease |
Associate Professor Kay Stewart |
(4CPA) |
| Increasing Patient Demand for Home Medicines Review: A Marketing Plan |
Professor Lesley White |
(4CPA) |
| An integrated model for disease state management (DSM) in diabetes: collaboration of the community pharmacist and GP in continuity of care |
Associate Professor Ines Krass |
(3CPA) |
| An integrated service, initiated by community pharmacists, for the prevention of osteoporosis |
Dr Susan Taylor |
(3CPA) |
| The Integration of Complementary Medicines in Community Pharmacy Practice |
Professor Michael Dooley |
(4CPA) |
| An investigation into business and professional facilitators for change for the pharmacy profession in light of the Third Guild/Government Agreement |
Professor Charlie Benrimoj |
(3CPA) |
| Investigating Consumer Medicine Information (I-CMI) Project |
Dr Parisa Aslani |
(4CPA) |
| Managing mental illness and promoting and sustaining recovery |
Mr Wayne Kinrade |
(4CPA) |
| Medication management and education of osteoarthritis patients: evaluation of a role for community pharmacists |
Dr Tim Chen |
(3CPA) |
| Mental Health |
Professor Amanda Wheeler, Griffith University |
(5CPA) |
| Mentor support program |
Leone Coper |
(3CPA) |
| A National Funding Model for Pharmacotherapy Treatment for Opioid Dependence in Community Pharmacy |
Dr Anne-Marie Feyer |
(4CPA) |
| National trial to test strategies to improve medication compliance in a community pharmacy setting |
Dr Anne-Marie Feyer |
(4CPA) |
| The Nature, Extent and Impact of Triage Provided By Community Pharmacy in Victoria |
Professor Colin Chapman |
(4CPA) |
| Pharmacist Assessment and Adherence, Risk and Treatment in Cardiovascular Disease |
Mr Kevin McNamara |
(4CPA) |
| Pharmacy and general practice disease management collaboration |
Reitai Minogue |
(3CPA) |
| Pharmacy Asthma Action Plan – Pharmacists receiving remuneration for addressing the issues for people with asthma in the community |
Dr Sinthia Bosnic- Anticevich |
(3CPA) |
| Pharmacy Asthma Care Program |
Professor Carol Armour |
(3CPA) |
| Pharmacy Cardiovascular Health Care Model |
Professor Greg Peterson |
(3CPA) |
| Pharmacy Continence Care Program |
Professor Rosemary Calder |
(3CPA) |
| Pharmacy Diabetes Care Program |
Associate Professor Ines Krass |
(3CPA) |
| Pharmacy Dispensing Records to Identify and Educate Patients with Suboptimal Asthma Management |
Dr Shane Jackson |
(4CPA) |
| Pharmacy Workforce Planning |
Mr Lee Ridoutt |
(4CPA) |
| Pharmacy workforce supply and demand 2000-2010 |
Dr David Gadiel |
(3CPA) |
| Pharmacy-based Model Enabling Patient Self-monitoring of Warfarin: Development and Evaluation |
Dr Luke Bereznicki |
(4CPA) |
| Pharmacy-based program to tackle coronary heart disease in the Australian community |
Professor Greg Peterson |
(3CPA) |
| Professional Collaboration |
John Cannings, PricewaterhouseCoopers |
(5CPA) |
| Professional pharmacy services to private hospitals |
Rebekah Moles |
(3CPA) |
| Quantification of facilitators to accelerate uptake of cognitive pharmaceutical services (CPS) in community pharmacy |
Professor Charlie Benrimoj |
(3CPA) |
| Reference data base of Australia’s community pharmacies: analysis of national survey |
Con Berbatis |
(3CPA) |
| Review of DMMR software |
Wayne Kinrade |
(3CPA) |
| The Role of Community Pharmacy in Post Hospital Management of Patients Initiated on Warfarin |
Professor Greg Peterson |
(4CPA) |
| The Role of Pharmacists in Sleep Health: a Screening, Awareness and Monitoring Program |
Dr Bandana Saini |
(4CPA) |
| The role of pharmacy in immunisation |
Professor Joan Dawes |
(3CPA) |
| The Role of the Pharmacist in the Provision of Palliative Care |
Professor Moyez Jiwa |
(4CPA) |
| Rural community pharmacists integrating care for people with complex health needs |
Dr Lisa Nissen |
(3CPA) |
| The value of pharmacist professional services in the community setting |
Dr Libby Roughhead |
(3CPA) |
| VALMER (the Economic Value of Home Medicines Reviews) |
Dr Peter Tenni |
(4CPA) |
| Weight Management |
Associate Professor Allan Everett |
(3CPA) |
| Workforce and career path options for pharmacy assistants |
Wayne Kinrade |
(3CPA) |
| Woundcare benchmarking in community pharmacy – Piloting a QA indicator development |
Dr Julie Stokes |
(3CPA) |